In this week’s newsletter

✅ Open AI’s Deep Research can provide novel insights. ✅ Gene tuning technology. ✅ From geroscience to gerophysics. ✅ Cryonics goes mainstream. ✅ The longevity biotech landscape.

🤙🏼 Want to connect? Add me on LinkedIn. 🙏🏼 Not subscribed to the LEVITY podcast on Youtube yet? Do it here. 🎧 More of a listener? The LEVITY podcast is also available on Spotify, Apple Podcasts and other places.

A few quick notes before we dive in

1️⃣ A warm welcome to all new subscribers! I’m incredibly grateful that this newsletter continues to grow every month.

2️⃣ To those of you who’ve upgraded to PREMIUM - thank you! Your support means the world. As a PREMIUM member, you get the ad-free version, full archive access, and, going forward, more exclusive content.

Alright, let’s get this show on the road!

Deep Research is a preview of what's coming

Imagine an AI system with access to all academic literature and extensive datasets on gene expression, protein interactions, and omics data. It could analyze clinical trials, industry reports, and global public health statistics on aging populations and disease prevalence.

Imagine this AI system operating autonomously for up to 30 minutes, continuously updating its knowledge base as it encounters new information, interpreting and analyzing its findings to provide novel insights.

Or don’t imagine it, as this future is now a reality, thanks to OpenAI's new Deep Research agent.

Deep Research is already capable of performing high-level strategic business intelligence, financial and market analysis, and legal due diligence - tasks that typically take days or weeks and cost thousands of dollars. Unsurprisingly, people have also begun using it for medical insights, including Felipe Millon at OpenAI, whose wife was recently diagnosed with breast cancer. He shared his experience on X:

”Because I had preview access to ChatGPT’s new Deep Research feature, I decided to give it a shot. We uploaded her surgical pathology report and asked for guidance on whether radiation would be beneficial. What happened next was mind-blowing. It didn’t just confirm what our oncologists mentioned - it went deeper. It cited studies I’d never heard of and adapted when we added details like her age and genetic factors. We fact-checked each study. They were spot on.”

I want to highlight a few key phrases here, just in case they didn’t make your jaw drop. First, I mentioned that Deep Research can ”provide novel insights”. Then, Millon described his experience as mind-blowing - not just because it confirmed what oncologists had told him, but because ”it went deeper”. In other words, Deep Research isn’t just about saving time and money. It’s about uncovering insights that emerge when an intelligent agent processes vast amounts of data, reasons through it, and identifies connections and possibilities that no human had considered before.

Subscribe to LEVITY Premium to read the rest.